Matches in SemOpenAlex for { <https://semopenalex.org/work/W2425231553> ?p ?o ?g. }
- W2425231553 abstract "Real-world data regarding anti-tumor necrosis factor alpha (anti-TNFα) biologic therapy use in psoriatic arthritis (PsA) are limited; therefore, we described treatment patterns and costs of anti-TNFα therapy in PsA patients in the United States.PsA patients (N = 990) aged ≥18 years who initiated anti-TNFα therapy were selected from MarketScan claims databases (10/1/2009 to 9/30/2010). Number of patients on first- (n = 881), second- (n = 72), or third- or greater (n = 37) line of anti-TNFα therapy, persistence, time-to-switch or modification, pharmacy and medical costs (measured per patient per month [PPPM]) for each line of therapy were observed during the 3-year follow-up.PsA patients receiving only one line of anti-TNFα therapy remained on first-line for ~17 months while those who switched to second- or third- or greater persisted on first-line for ~11 to 12 months, respectively. Time to first-line modification was longer for patients who switched to third- or greater line therapy (7 months) than those who did not switch or switched to second-line (range, ~2 to 4 months). Time-to-switch and time to first-line modification was progressively shorter with each line of therapy for patients who received third- or greater line. PPPM medical costs were higher for patients who did not switch ($322) than those who switched to second- ($167) or third- or greater ($217) line. PPPM pharmacy costs were greater for patients with third- or greater line therapy ($2539) than those who did not switch ($1985) or switched to second-line ($2045).While the majority of patients received only one line of anti-TNFα therapy, a subset of patients switched to multiple lines of therapy during the 3-year follow-up period. Persistence and therapy modifications differed between these patients and those receiving only one line. Overall medical costs were highest for patients who did not switch, and pharmacy costs increased as patients switched to each new line of therapy." @default.
- W2425231553 created "2016-06-24" @default.
- W2425231553 creator A5005260055 @default.
- W2425231553 creator A5005950745 @default.
- W2425231553 creator A5014809059 @default.
- W2425231553 creator A5016598918 @default.
- W2425231553 creator A5022158629 @default.
- W2425231553 creator A5065966188 @default.
- W2425231553 date "2016-06-14" @default.
- W2425231553 modified "2023-09-30" @default.
- W2425231553 title "Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis" @default.
- W2425231553 cites W1552422862 @default.
- W2425231553 cites W1599887951 @default.
- W2425231553 cites W1899264062 @default.
- W2425231553 cites W1989931772 @default.
- W2425231553 cites W2004007517 @default.
- W2425231553 cites W2005564969 @default.
- W2425231553 cites W2008702602 @default.
- W2425231553 cites W2029894811 @default.
- W2425231553 cites W2035609762 @default.
- W2425231553 cites W2041516336 @default.
- W2425231553 cites W2060221163 @default.
- W2425231553 cites W2063671947 @default.
- W2425231553 cites W2064262907 @default.
- W2425231553 cites W2068614670 @default.
- W2425231553 cites W2069812497 @default.
- W2425231553 cites W2084560920 @default.
- W2425231553 cites W2091507624 @default.
- W2425231553 cites W2096020283 @default.
- W2425231553 cites W2099148197 @default.
- W2425231553 cites W2102864252 @default.
- W2425231553 cites W2109172918 @default.
- W2425231553 cites W2111430036 @default.
- W2425231553 cites W2118596556 @default.
- W2425231553 cites W2120407721 @default.
- W2425231553 cites W2120557677 @default.
- W2425231553 cites W2128340413 @default.
- W2425231553 cites W2140168538 @default.
- W2425231553 cites W2141497102 @default.
- W2425231553 cites W2166575175 @default.
- W2425231553 cites W2167894048 @default.
- W2425231553 cites W2171122996 @default.
- W2425231553 cites W2171249245 @default.
- W2425231553 cites W2184636809 @default.
- W2425231553 cites W2270726913 @default.
- W2425231553 cites W2531177468 @default.
- W2425231553 cites W4231010620 @default.
- W2425231553 cites W4244483270 @default.
- W2425231553 cites W56809741 @default.
- W2425231553 doi "https://doi.org/10.1186/s12891-016-1102-z" @default.
- W2425231553 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4908678" @default.
- W2425231553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27301458" @default.
- W2425231553 hasPublicationYear "2016" @default.
- W2425231553 type Work @default.
- W2425231553 sameAs 2425231553 @default.
- W2425231553 citedByCount "29" @default.
- W2425231553 countsByYear W24252315532016 @default.
- W2425231553 countsByYear W24252315532017 @default.
- W2425231553 countsByYear W24252315532018 @default.
- W2425231553 countsByYear W24252315532019 @default.
- W2425231553 countsByYear W24252315532020 @default.
- W2425231553 countsByYear W24252315532021 @default.
- W2425231553 countsByYear W24252315532022 @default.
- W2425231553 countsByYear W24252315532023 @default.
- W2425231553 crossrefType "journal-article" @default.
- W2425231553 hasAuthorship W2425231553A5005260055 @default.
- W2425231553 hasAuthorship W2425231553A5005950745 @default.
- W2425231553 hasAuthorship W2425231553A5014809059 @default.
- W2425231553 hasAuthorship W2425231553A5016598918 @default.
- W2425231553 hasAuthorship W2425231553A5022158629 @default.
- W2425231553 hasAuthorship W2425231553A5065966188 @default.
- W2425231553 hasBestOaLocation W24252315531 @default.
- W2425231553 hasConcept C104863432 @default.
- W2425231553 hasConcept C126322002 @default.
- W2425231553 hasConcept C17991360 @default.
- W2425231553 hasConcept C1862650 @default.
- W2425231553 hasConcept C198451711 @default.
- W2425231553 hasConcept C2776260265 @default.
- W2425231553 hasConcept C2776694085 @default.
- W2425231553 hasConcept C2777226972 @default.
- W2425231553 hasConcept C2777575956 @default.
- W2425231553 hasConcept C2909905744 @default.
- W2425231553 hasConcept C512399662 @default.
- W2425231553 hasConcept C71924100 @default.
- W2425231553 hasConceptScore W2425231553C104863432 @default.
- W2425231553 hasConceptScore W2425231553C126322002 @default.
- W2425231553 hasConceptScore W2425231553C17991360 @default.
- W2425231553 hasConceptScore W2425231553C1862650 @default.
- W2425231553 hasConceptScore W2425231553C198451711 @default.
- W2425231553 hasConceptScore W2425231553C2776260265 @default.
- W2425231553 hasConceptScore W2425231553C2776694085 @default.
- W2425231553 hasConceptScore W2425231553C2777226972 @default.
- W2425231553 hasConceptScore W2425231553C2777575956 @default.
- W2425231553 hasConceptScore W2425231553C2909905744 @default.
- W2425231553 hasConceptScore W2425231553C512399662 @default.
- W2425231553 hasConceptScore W2425231553C71924100 @default.
- W2425231553 hasFunder F4320310388 @default.
- W2425231553 hasIssue "1" @default.
- W2425231553 hasLocation W24252315531 @default.
- W2425231553 hasLocation W24252315532 @default.